
    
      Prior to initiation of study treatment all patients are screened and baseline lab values are
      taken. Patients then receive the study treatment, FORTOVASE, two times a day plus 2 new
      NRTI's. Assessments will be performed at specified intervals throughout the duration of
      treatment.
    
  